Navigation Links
Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
Date:5/2/2012

pps address the mobile world we live in by helping our recipients find information and answers about their device in the palm of their hand."

To download the Nucleus Support App, visit iTunes or Google Play for Android.

About Cochlear Implants
Cochlear implants are a proven medical option for children as young as 12 months old with profound hearing loss in both ears and for individuals who are two years or older with severe-to-profound hearing loss in both ears whom obtain little or no benefit from hearing aids. They are electronic devices, which bypass damaged hair cells in the inner ear, or cochlea, and stimulate the hearing nerve directly.

About Bone Anchored Hearing Solutions 
Bone anchored hearing solutions are a proven medical option for adults and children with conductive hearing loss, mixed hearing loss, and single-sided sensorineural deafness meeting the candidacy criteria. They are designed to provide audibility and to improve the communication abilities of those who receive little or no benefit from hearing aids. The Baha® System sends external sounds to the inner ear through the bone by passing the outer and middle ear.

About Cochlear Americas
Cochlear Americas is the world leader in advanced hearing technologies. Since launching the first multichannel cochlear implant system more than 25 years ago, Cochlear Limited and its U.S. headquarters have brought the miracle of sound to more than 250,000 people with hearing loss across the globe. For more information about Cochlear Americas products, please visit www.cochlearamericas.com.


'/>"/>
SOURCE Cochlear Americas
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cochlear™ Americas Launches Smartphone App for Baha® 3 Recipients
2. Cochlear™ Americas Brings Total Scholarships Awarded to $320,000, Adds New Program
3. Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
4. Medical Devices - Americas
5. Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
6. Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately Respond to Traditional Corticosteroid Therapy, According to New Data Presented at the 5th Joint Congress of the European and Americas Committees for Treatment and Researc
7. Generic Drugs: The Global Market: Focus on the Americas
8. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
9. Reportlinker Adds Butadiene Market In Americas To 2020 - Recovery In End Use Markets Providing Positive Demand Growth In The Region
10. Cochlear Americas Announces 2011 Graeme Clark Scholarship Winners
11. Astellas Mobilizes 1,300+ Employees in the Americas to Participate in First Annual Changing Tomorrow Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... 2014  Abbott announced today positive one-year clinical ... randomized, controlled trial comparing the safety and effectiveness ... market-leading metallic XIENCE family of DES.  The trial, ... included 501 people with coronary artery disease (CAD), ... results were featured at a late-breaking session at ...
(Date:9/12/2014)... Colorado eye care provider Vision Care Specialists announced expansion ... high quality eye care services. Photo - http://photos.prnewswire.com/prnh/20140912/145684 ... locations in Aurora , Lakewood ... days a week. Hours are Monday, Tuesday, Thursday and Friday 7:45 ... Saturday 7:45 AM to 2:30 PM. The downtown Denver ...
(Date:9/12/2014)...   Synthetic Biologics, Inc. (NYSE MKT: ... and drug programs targeting specific pathogens that cause ... U.S. Food and Drug Administration (FDA) has granted ... monoclonal antibody (mAb) combination for the treatment of ... the U.S., Orphan Drug Designation provides a variety ...
Breaking Medicine Technology:ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 2Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 3Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 2Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 3
... and Efficacy Data Reported ... Enrollment Advancing Ahead of Schedule, SOUTH SAN FRANCISCO, ... ) today presented an update of interim,data from the ... product,candidate, voreloxin (formerly SNS-595), in platinum-resistant ovarian,cancer patients at ...
... Results Confirm Previously Demonstrated Survival Advantages of Tarceva in ... This Difficult-to-Treat Disease ... - ABSTRACT No: 4507, ... Tarceva (erlotinib) and chemotherapy significantly,improves the time patients with metastatic pancreatic cancer ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 2Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 3
(Date:9/15/2014)... (PRWEB) September 15, 2014 Insurers ... initiatives that bring providers on board as partners ... satisfaction. When bundled payment programs are designed properly ... incentives, incentivize hospitals to work collaboratively with providers, ... tally. On Sept. 24, the Atlantic Information Services ...
(Date:9/15/2014)... New Jersey, Sept 9, 2014 – New Jersey ... firm of Ricci Tyrrell Johnson & Grey, PLLC, has ... No. 8,774,911 from the United States Patent and Trademark ... locator instrument is invented by Dr. Lee M. Buono ... in minimally-invasive spine surgery. , Precise pedicle location is ...
(Date:9/15/2014)... September 15, 2014 Recently, Top10BestSEOHosting.com ... announced that GreenGeeks ( http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), IX Web ... suppliers in 2014. , “These companies have outperformed ... customer support, so that we call them the ... people can get the best web hosting to ...
(Date:9/14/2014)... 14, 2014 When active, the protein ... several human cancers including pancreatic, prostate, lung, colon and ... available. A study published today in the journal Nature ... these Ral proteins: "When you want to keep an ... shut. We took another approach – we put a ...
(Date:9/14/2014)... -- Getting enough sleep each night may mean you,re less likely ... study suggests. The study included more than 3,700 people in ... of seven years. Those who slept less than six hours ... to have extended absences from work due to illness, the investigators ... work due to sickness were those who slept between seven and ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Nature: New drug blocks gene driving cancer growth 2Health News:Nature: New drug blocks gene driving cancer growth 3Health News:A Good Night's Sleep May Mean a Good Day's Work 2
... 57 million Americans currently living with "pre-diabetes" could benefit from ... a new study published in this month,s American Journal ... Weight Watchers group program, overweight or obese adults who attended ... lost weight, but also significantly reduced fasting glucose and insulin ...
... Georgia Institute of Technology has received a $100,000 Grand ... Foundation. The grant will support an innovative global health ... in Georgia Tech,s School of Mechanical Engineering, titled "Complement-based ... grants announced by the Gates Foundation in the fourth ...
... successful testing of a sensor that can instantly tell whether ... by emergency room doctors to determine whether a patient has ... diabetics do not take enough insulin. Someday the technology may ... determine whether they need more insulin. A report on the ...
... Through ... and rare diseases are possible before they ever manifest. The future of medicine starts ... (PRWEB) ... world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and ...
... ... ... -- IT-Lifeline, the Northwest’s foremost provider of disaster recovery and business continuity solutions, and ... have entered into a joint marketing agreement to provide a suite of Disaster Recovery ...
... fingerroot inhibited production of carcinogenic compounds , THURSDAY, May ... to your burgers before tossing them on the grill ... of the meat, but they can also cut the ... beef. , Scientists at Kansas State University (KSU) found ...
Cached Medicine News:Health News:New study finds attending Weight Watchers meetings helps reduce the risk for type 2 diabetes 2Health News:Georgia Tech awarded Gates Foundation grant for innovative global health research 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 2Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 3Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: